Latest JMP Stories
AxoGen CEO to provide Company Updates at JMP Securities Conference Alachua, FL (PRWEB) July 01, 2013 AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that Karen Zaderej, President and Chief Executive Officer, is scheduled to present at the 8th Annual JMP Securities Healthcare Conference in New York. Event: The 8th Annual JMP...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.